Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study

INTRODUCTION: A common treatment for localized prostate cancer (PCa) is radiotherapy; however, effectiveness is hampered because of toxicities and tumor resistance. Cyclooxygenase-2 (COX-2) inhibitors have been identified as potential agents that could improve treatment outcomes and have demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Liam, Christie, David, Arora, Devinder, Anoopkumar-Dukie, Shailendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125379/
https://www.ncbi.nlm.nih.gov/pubmed/32257976
http://dx.doi.org/10.1016/j.prnil.2019.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125379/
https://www.ncbi.nlm.nih.gov/pubmed/32257976
http://dx.doi.org/10.1016/j.prnil.2019.10.004

Ejemplares similares